Literature DB >> 32382152

Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry.

Paul Hofman1,2, Pascal Puchois3, Patrick Brest4, Hicham Lahlou3, Daniel Simeon-Dubach5.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32382152     DOI： 10.1038/s41591-020-0890-8

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  2 in total

1.  Artificial intelligence-enabled rapid diagnosis of COVID-19 patients.

Authors:  Xueyan Mei; Hao-Chih Lee; Kaiyue Diao; Mingqian Huang; Bin Lin; Chenyu Liu; Zongyu Xie; Yixuan Ma; Philip M Robson; Michael Chung; Adam Bernheim; Venkatesh Mani; Claudia Calcagno; Kunwei Li; Shaolin Li; Hong Shan; Jian Lv; Tongtong Zhao; Junli Xia; Qihua Long; Sharon Steinberger; Adam Jacobi; Timothy Deyer; Marta Luksza; Fang Liu; Brent P Little; Zahi A Fayad; Yang Yang
Journal:  medRxiv       Date:  2020-04-17

2.  Transoesophageal endoscopic removal of a benign mediastinal tumour: a new field for endotherapy?

Authors:  Pingting Gao; Quanlin Li; Jianwei Hu; Jiaxin Xu; Shengli Lin; Mingyan Cai; Lili Ma; Weifeng Chen; Yiqun Zhang; Shi-Yao Chen; Yunshi Zhong; Liqing Yao; Pinghong Zhou
Journal:  Gut       Date:  2020-06-12       Impact factor: 23.059
  2 in total
  9 in total

Review 1.  Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond.

Authors:  Daniel Simeon-Dubach; Marianne K Henderson
Journal:  Biopreserv Biobank       Date:  2020-10-08       Impact factor: 2.300

Review 2.  The Impact of COVID-19 on National Clinical Trials Network Breast Cancer Trials.

Authors:  Amara Ndumele; Ko Un Park
Journal:  Curr Breast Cancer Rep       Date:  2021-05-12

3.  [Management of samples in pathology laboratories and biobanks during the Covid-19 pandemic].

Authors:  Paul Hofman
Journal:  Rev Francoph Lab       Date:  2021-01-07

Review 4.  Biobanking and risk assessment: a comprehensive typology of risks for an adaptive risk governance.

Authors:  Kaya Akyüz; Gauthier Chassang; Melanie Goisauf; Łukasz Kozera; Signe Mezinska; Olga Tzortzatou; Michaela Th Mayrhofer
Journal:  Life Sci Soc Policy       Date:  2021-12-13

Review 5.  The Availability of Human Biospecimens to Support Biomarker Research.

Authors:  Tamsin E Tarling; Jennifer A Byrne; Peter H Watson
Journal:  Biomark Insights       Date:  2022-04-19

Review 6.  An Update on Molecular Diagnostics for COVID-19.

Authors:  Khursheed Ul Islam; Jawed Iqbal
Journal:  Front Cell Infect Microbiol       Date:  2020-11-10       Impact factor: 5.293

Review 7.  Basic principles of biobanking: from biological samples to precision medicine for patients.

Authors:  Laura Annaratone; Giuseppe De Palma; Giuseppina Bonizzi; Anna Sapino; Gerardo Botti; Enrico Berrino; Chiara Mannelli; Pamela Arcella; Simona Di Martino; Agostino Steffan; Maria Grazia Daidone; Vincenzo Canzonieri; Barbara Parodi; Angelo Virgilio Paradiso; Massimo Barberis; Caterina Marchiò
Journal:  Virchows Arch       Date:  2021-07-13       Impact factor: 4.064

Review 8.  Challenges and issues surrounding the use for translational research of human samples obtained during the COVID-19 pandemic from lung cancer patients.

Authors:  Paul Hofman
Journal:  Transl Lung Cancer Res       Date:  2020-08

Review 9.  Considerations for diagnostic COVID-19 tests.

Authors:  Olivier Vandenberg; Delphine Martiny; Olivier Rochas; Alex van Belkum; Zisis Kozlakidis
Journal:  Nat Rev Microbiol       Date:  2020-10-14       Impact factor: 78.297
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.